Oxycodone is commonly detectable in urine for about 1 to 1.5 days in SAMHSA TIP 63, while blood and saliva usually reflect more recent exposure and hair can provide a retrospective window of roughly 90 days. Repeated use, laboratory cutoff and test method can extend or shorten the practical window.

The noticeable opioid effect ends much sooner than the longest testing window. Oxycodone is also metabolized into compounds such as noroxycodone and oxymorphone, which can contribute to toxicology interpretation.

Oxycodone Drug Test Timeline

Urine About 1 to 1.5 days in SAMHSA TIP 63; longer practical windows can occur with repeated use and different cutoffs
Blood Usually a recent-use window around the first day
Saliva Controlled single-dose research found mean oxycodone detection around 34 hours at a sensitive oral-fluid cutoff
Hair Often used for an approximately 90-day retrospective window
Important metabolites Noroxycodone and oxymorphone

How Long Does Oxycodone Stay in Urine?

SAMHSA TIP 63 lists oxycodone with a urine window of about 1 to 1.5 days and notes that the detection period varies with the cutoff. The table also notes that oxycodone may not reliably trigger a generic opiate immunoassay and can be tested for specifically.

Repeated oxycodone use can produce overlapping parent drug and metabolite exposure. A person using pills daily may therefore remain detectable longer than someone with one isolated exposure.

Urine testing commonly looks for oxycodone and metabolites such as oxymorphone. More specific confirmatory testing can distinguish oxycodone-related compounds from other opioids.

M30, IP 204, RP 10 325 and 512 pills all follow the oxycodone testing framework when the tablets are legitimate pharmaceutical products.

How Long Does Oxycodone Stay in Blood?

Blood gives a shorter and more recent view of oxycodone exposure. Controlled studies of oxycodone collect measurable blood concentrations across the first day after a dose, with concentrations declining as metabolism and elimination progress.

A blood result is more closely tied to recent circulating drug than a hair test. Timing, formulation, dose history and assay sensitivity affect how long oxycodone remains measurable.

Immediate-release and extended-release oxycodone can create different concentration curves even though the same parent drug is being tested.

In controlled oral-fluid studies, detection often centers on recent exposure, but the exact analytical window depends on the laboratory method and cutoff.

How Long Does Oxycodone Stay in Saliva?

Oral fluid is useful for relatively recent oxycodone exposure. In a controlled study after a single 20 mg controlled-release dose, oxycodone was detected quickly in oral fluid and the mean detection time was about 34 hours at a 1 ng/mL cutoff.

That does not create one universal 34-hour rule. Different cutoffs and collection methods change the practical result, and repeated use can alter the amount of drug present.

A practical consumer summary is roughly one to two days for saliva, with the understanding that some assays can detect shorter or longer periods.

Oral fluid generally covers a shorter period than urine or hair.

How Long Does Oxycodone Stay in Hair?

Hair testing looks back across a much longer period because oxycodone becomes incorporated into hair as it grows. A roughly 90-day window is common when about three months of head-hair growth is analyzed.

Research has demonstrated oxycodone detection in hair from users and workplace-testing populations. Hair testing is poor for determining whether someone is currently intoxicated and is better suited to retrospective exposure.

The exact time span depends on the length and segment of hair analyzed.

Hair can remain positive long after blood, saliva and urine have returned to negative.

Oxycodone, Noroxycodone and Oxymorphone

Oxycodone is metabolized through pathways that form noroxycodone and oxymorphone. Those metabolites can help laboratories interpret exposure.

Noroxycodone is formed mainly through CYP3A pathways, while oxymorphone is formed through CYP2D6. Different specimens and tests may target different combinations of the parent drug and metabolites.

A positive oxymorphone result can occur as part of oxycodone metabolism. The full toxicology pattern is more informative than treating one metabolite name as a separate drug history automatically.

This metabolism is also why oxycodone can remain detectable after the person no longer feels the strongest opioid effect.

Why Daily Oxycodone Use Can Extend Detection

Daily use repeatedly adds new oxycodone before earlier drug and metabolites are fully eliminated. That creates overlapping exposure and can extend the practical detection period.

Total amount, frequency, formulation, age, liver function, kidney function and interacting medications can all influence the concentration curve.

Someone using M30s, Percs or other oxycodone pills throughout the day may therefore have a different testing window from someone who used one dose once.

For a person with opioid dependence, repeated use also means the testing question often overlaps with withdrawal and addiction concerns.

Do M30, IP 204, RP 10 325 and 512 Have Different Test Windows?

Legitimate versions of these pills all contain oxycodone, so the core testing target is the same opioid and its metabolites. Strength and repeated use can affect how much drug is present, but the imprint itself does not create a different metabolic pathway.

M30 is oxycodone 30 mg without acetaminophen in the legitimate product. IP 204 and RP 10 325 contain oxycodone 10 mg with acetaminophen 325 mg. The 512 pill contains oxycodone 5 mg with acetaminophen 325 mg.

Counterfeit street pills change the answer because the laboratory detects the chemical that was actually present. A pressed M30 can produce a toxicology result that differs from pharmaceutical oxycodone.

The Oxycodone Street Names and Slang guide maps these pill identities to terms such as 30s, Blues, 512s, Percs and Roxies.

How Long Do Oxycodone Effects Last Compared With Testing?

The euphoric, sedating and pain-relieving effects of immediate-release oxycodone are much shorter than a hair-testing window and usually shorter than urine detection.

A person can feel sober while oxycodone metabolites remain detectable.

This difference is especially important for people using repeatedly, because a new dose can be taken before the previous exposure has fully cleared.

Testing timelines describe laboratory detectability. Body effects and withdrawal can follow different timelines and are covered separately.

How Oxycodone Formulation Changes the Timeline

Immediate-release oxycodone reaches and leaves the circulation on a different schedule from extended-release oxycodone. The same drug is present, but the release pattern changes how concentrations rise and fall.

That can affect both how long effects are felt and how long measurable concentrations remain above a laboratory cutoff. A person taking repeated extended-release doses can have a more prolonged exposure profile than someone who took one immediate-release tablet.

M30, IP 204, RP 10 325 and 512 are commonly encountered as immediate-release oxycodone products when legitimate. Extended-release oxycodone has a different formulation and pharmacokinetic context.

The testing table at the top is therefore a practical summary, while the exact detection window still depends on formulation and repeated use.

Can Oxycodone Show Up as Oxymorphone?

Yes. Oxymorphone can appear as a metabolite of oxycodone through CYP2D6 metabolism. Noroxycodone is another major metabolite formed mainly through CYP3A pathways.

A toxicology report can therefore contain more than the parent drug name. The metabolite pattern can help support recent oxycodone exposure.

This becomes especially relevant when a person is surprised by an oxymorphone result after reporting oxycodone use. The finding can fit normal metabolism depending on the overall pattern and testing method.

The laboratory interpretation should consider all detected compounds together, especially when multiple opioids or counterfeit pills may be involved.

What a Positive Oxycodone Test Can and Cannot Tell You

A positive result shows that oxycodone or a relevant metabolite was detected above the test’s cutoff. It does not by itself identify the exact pill imprint, prove a specific dose, or establish when during the detection window the drug was taken.

A urine test also cannot distinguish M30 from IP 204 or RP 10 325 when all of those legitimate pills contain oxycodone. The imprint belongs to the medication history, while the laboratory result reflects the drug exposure.

Counterfeit pills add another layer because a person can report an M30 while toxicology shows a different opioid. That discrepancy may reflect the street supply instead of inaccurate reporting.

For treatment programs, the test is most useful when it is interpreted alongside the person’s pill names, use frequency, withdrawal symptoms and overdose history.

Oxycodone Testing and Counterfeit M30s

A street pill sold as oxycodone can contain another opioid. In that situation, the test may reflect the actual exposure and may not show the oxycodone pattern the user expected.

This is particularly relevant to counterfeit M30s because the M30 name is heavily used in the illicit opioid market.

Someone can identify as an oxycodone user while their recent street supply has introduced another opioid into the toxicology profile.

Testing history, overdose response and withdrawal pattern can help treatment clinicians understand that changing exposure.

Why the Urine Window Gets the Most Search Interest

Urine testing is the specimen most people encounter in employment, treatment, monitoring and many routine toxicology settings, so it drives a large share of oxycodone detection searches.

For oxycodone, the SAMHSA TIP 63 estimate of about 1 to 1.5 days is a useful reference point, while repeated use and different cutoffs can produce a longer practical window.

Someone using oxycodone every day should expect more overlap between doses and metabolites than someone with one isolated exposure.

The practical detection window changes with specimen type, laboratory cutoff, frequency of use and individual metabolism.

Why Oxycodone May Need a Specific Opioid Test

SAMHSA TIP 63 notes that oxycodone can screen negative on a general opiate immunoassay and can be tested for specifically. That matters because semisynthetic opioids do not all react the same way on broad screening tests.

A specific oxycodone assay or confirmatory laboratory method can identify oxycodone-related compounds more reliably when the test is designed for them.

This is also why the name of the test matters when someone compares results from two settings. A broad opiate screen and an oxycodone-specific test are not necessarily measuring the same target.

Frequently Asked Questions About Oxycodone Detection

How long does oxycodone stay in urine?

SAMHSA TIP 63 lists about one to one and a half days at the referenced cutoff, with longer practical windows possible depending on test method and repeated use.

How long does oxycodone stay in blood?

Blood mainly reflects recent exposure, commonly around the first day.

How long does oxycodone stay in saliva?

A practical range is about one to two days. Controlled research found mean oral-fluid detection around 34 hours at a sensitive cutoff.

How long does oxycodone stay in hair?

Hair testing commonly uses about a 90-day retrospective window when roughly three months of head hair are analyzed.

Does M30 stay in the system longer than other oxycodone pills?

The imprint does not create a different metabolic pathway. Dose, frequency, formulation and whether the pill was actually pharmaceutical oxycodone are more relevant.

Sources

Part of the Oxycodone resource silo

Continue exploring Oxycodone

Follow the topic in sequence or browse the full Oxycodone resource hub.

About This Article
Evidence-based sourcesSources verified August 17, 2026

Editorial standard

Rehabs.Today resource articles are written for educational and treatment-navigation purposes. For medical and drug-safety claims, we prioritize current primary or authoritative references such as FDA and DailyMed labeling, CDC, SAMHSA, NIH/NCBI resources, and peer-reviewed research when appropriate. Important limitations, uncertainty, and differences between population-level evidence and individual medical advice are stated where they matter.

How to use this information

This article provides general educational information. It is not a diagnosis, prescription, personalized taper, or substitute for advice from a physician, pharmacist, or other qualified healthcare professional. Do not start, stop, combine, or change a prescribed medication solely because of information on this page.

Emergency information

If someone cannot be awakened, is breathing slowly or abnormally, or may be experiencing an opioid overdose, seek emergency medical help immediately and give naloxone if it is available.

Treatment-directory transparency

Some Rehabs.Today articles link to treatment directories and provider resources. Those links are for navigation and do not replace independent medical assessment. Medical claims in the article should be evaluated from the cited evidence, not from whether a treatment provider is linked.